Treatment and surveillance strategies in achalasia: An update

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 6, 2011, Pages 311-319

  Eckardt, Alexander J ^a   Eckardt, Volker F ^a  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; ISOSORBIDE DINITRATE; NIFEDIPINE; NITRIC ACID DERIVATIVE; SILDENAFIL;

BEDTIME DOSAGE; CLINICAL EFFECTIVENESS; CONSERVATIVE TREATMENT; DIAGNOSTIC IMAGING; DISEASE DURATION; DISEASE SURVEILLANCE; ESOPHAGEAL STENTING; ESOPHAGUS ACHALASIA; ESOPHAGUS MYOTOMY; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MULTICENTER STUDY (TOPIC); PATIENT MONITORING; PATIENT PREFERENCE; PNEUMATIC DILATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPEATED DRUG DOSE; REVIEW; ROBOTICS; STENT; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ESOPHAGEAL ACHALASIA; HUMANS; TREATMENT OUTCOME;

EID: 79958105098     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2011.68     Document Type: Review

References (101)

1. Francis, D. L. & Katzka, D. A. Achalasia: update on the disease and its treatment. Gastroenterology 139, 369-374 (2010).
2. Gockel, H. R., et al. Achalasia: will genetic studies provide insights? Hum. Genet. 128, 353-364 (2010).
3. Boeckxstaens, G. E. Achalasia: virus-induced euthanasia of neurons? Am. J. Gastroenterol. 103, 1610-1612 (2008).
4. Vaezi, M. F., et al. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut 50, 765-770 (2002). (Pubitemid 34539036)
5. Andersson, M., et al. of the response to treatment in patients with idiopathic achalasia by the timed barium esophagogram: results from a randomized clinical trial. Dis. Esophagus 22, 264-273 (2009).
6. Gockel, I., et al. Pseudoachalasia: a case series and analysis of the literature. Scand. J. Gastroenterol. 40, 378-385 (2005). (Pubitemid 40546904)
7. Eckardt, V. F., Schmitt, T. & Kanzler, G. Transabdominal ultrasonography in achalasia. Scand. J. Gastroenterol. 39, 634-637 (2004). (Pubitemid 38916238)
8. Eckardt, A. J. & Eckardt, V. F. Current clinical approach to achalasia. World J. Gastroenterol. 28, 3969-3975 (2009).
9. Pandolfino, J. E. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 135, 1526-1533 (2008).
10. Salvador, R., et al. The preoperative manometric pattern predicts the outcome of surgical treatment of esophageal achalasia. J. Gastrointest. Surg. 14, 1635-1645 (2010).
11. Eckardt, V. F., Gockel, I. & Bernhard, G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 53, 629-633 (2004). (Pubitemid 38561438)
12. Hulselmans, M., et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin. Gastroenterol. Hepatol. 8, 30-35 (2010).
13. Eckardt, V. F., Stauf, B. & Bernhard, G. Chest pain in achalasia: patient characteristics and clinical course. Gastroenterology 116, 1300-1304 (1999). (Pubitemid 29258877)
14. Omura, N., et al. Effect of laparoscopic esophagomyotomy on chest pain associated with achalasia and prediction of therapeutic outcomes. Surg. Endosc. 25, 1048-1053 (2010).
15. Hoogerwerf, W. A. & Pasricha, P. J. Pharmacologic therapy in treating achalasia. Gastrointest. Clin. North Am. 11, 311-324 (2001).
16. Vaezi, M. F. & Richter, J. E. Current therapies for achalasia. Comparison of efficacy. J. Clin. Gastroenterol. 27, 21-35 (1998). (Pubitemid 28357621)
17. Bortolotti, M., et al. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology 118, 253-257 (2000). (Pubitemid 30067497)
18. Annese, V. & Bassotti, G. Non-surgical treatment of esophageal achalasia. World J. Gastroenterol. 12, 5763-5766 (2006). (Pubitemid 44594241)
19. Pasricha, J., et al. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 110, 1410-1415 (1996).
20. Boeckxstaens, G. E. Achalasia. Best Pract. Res. Clin. Gastroentrol. 21, 595-608 (2007). (Pubitemid 47074363)
21. Allescher, H. D., et al. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-up. Endoscopy 33, 1007-1017 (2001). (Pubitemid 33121074)
22. Annese, V., et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut 46, 597-600 (2000). (Pubitemid 30305774)
23. Fishman, V. M., et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am. J. Gastroenterol. 91, 1724-1730 (1996).
24. Wang, L., Li, Y. M. & Li, L. Meta-analysis of randomized and controlled treatment trials for achalasia. Dig. Dis. Sci. 54, 2303-2311 (2009).
25. Leyden, J. E., Moss, A. C. & MacMathuna, P. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. Cochrane Database Syst. Rev. Issue 18. Art. No.: CD005046. doi:10.1002/14651858.CD005046.pub2 (2006). (Pubitemid 46841203)
26. Zaninotto, G., et al. Randomized controlled trial of botulinum toxin versus laparoscopic Heller myotomy for esophageal achalasia. Ann. Surg. 239, 364-370 (2004). (Pubitemid 38229065)
27. Chan, K. C., et al. Short-term and long-term results of endoscopic balloon dilation for achalasia: 12 years experience. Endoscopy 36, 690-694 (2004). (Pubitemid 39149410)
28. Karamanolis, G., et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Am. J. Gastroenterol. 100, 270-274 (2005). (Pubitemid 40314508)
29. Kadakia, S. C. & Wong, R. K. Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am. J. Gastroenterol. 88, 34-38 (1993). (Pubitemid 23017939)
30. Ghoshal, U. C., et al. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence Am. J. Gastroenterol. 99, 2304-2310 (2004). (Pubitemid 40039357)
31. Zerbib, F., et al. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am. J. Gastroenterol. 101, 692-697 (2006).
32. Dobrucali, A., et al. Long-term results of graded pneumatic dilatation under endoscopic guidance in patients with primary esophageal achalasia. World J. Gastroenterol. 15, 3322-3327 (2004). (Pubitemid 39585474)
33. Chuah, S. K., et al. Clinical remission in endoscope-guided pneumatic dilation for the treatment of esophageal achalasia: 7-year follow-up results of a prospective investigation. J. Gastrointest. Surg. 13, 862-867 (2009).
34. Richter, J. E. Achalasia-an update. J. Neurogastroenterol. Motil. 16, 232-242 (2010).
35. West, R. L., et al. Long term results of pneumatic dilation in achalasia followed for more than 5 years. Am. J. Gastroenterol. 97, 1346-1351 (2002). (Pubitemid 34664775)
36. Vela, M. F., et al. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection. Am. J. Gastroenterol. 99, 1029-1036 (2004). (Pubitemid 38917804)
37. Eckardt, V. F., Aignherr, C. & Bernhard, G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 103, 1732-1738 (1992).
38. Kadakia, S. C. & Wong, R. K. Pneumatic balloon dilation for esophageal achalasia. Gastrointest. Endosc. Clin. N. Am. 11, 325-346 (2001).
39. Richter, J. E. Update on the management of achalasia: balloons, surgery and drugs. Expert Rev. Gastroenterol. Hepatol. 2, 435-445 (2008).
40. Gockel, I., et al. Heller myotomy for failed pneumatic dilation in achalasia: how effective is it? Ann. Surg. 239, 371-377 (2004). (Pubitemid 38229066)
41. Eckardt, V. F., Kanzler, G. & Westermeier, T. Complications and their impact after pneumatic dilation for achalasia: prospective long-term follow-up study. Gastrointest. Endosc. 45, 349-353 (1997). (Pubitemid 27426173)
42. Farhoomand, K., et al. Predictors of outcome of pneumatic dilation in achalasia. Clin. Gastroenterol. Hepatol. 2, 389-394 (2004). (Pubitemid 38561235)
43. Dagli, U., et al. Factors predicting outcome of balloon dilatation in achalasia. Dig. Dis. Sci. 54, 1237-1242 (2009).
44. Alderliesten, J., et al. Predictors for outcome of failure of balloon dilatation in patients with achalasia. Gut 60, 10-16 (2011).
45. Heller, E. Extramuköse Cardiaplastik beim chronischen Cardiospasmus mit Dilatation des Ösophagus [German]. Mitt. Grenzgeb Med. Chir. 27, 141-145 (1913).
46. SSAT patient care guidelines. Esophageal achalasia. J. Gastrointest. Surg. 11, 1210-1212 (2007).
47. Campos, G. M. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann. Surg. 249, 45-57 (2009).
48. Oelschlager, B. K., Chang, L. & Pellegrini, C. A. Improved outcome after extended gastric myotomy for achalasia. Arch. Surg. 138, 490-495 (2003).
49. Torquati, A., et al. Heller myotomy vs Heller myotomy plus Dor fundoplication: cost-utility analysis of a randomized trial. Surg. Endosc. 20, 389-393 (2006). (Pubitemid 43260494)
50. Rebecchi, F., et al. Randomized controlled trial of laparoscopic Heller myotomy plus Dor fundoplication versus Nissen fundoplication for achalasia: long-term results. Ann. Surg. 248, 1023-1030 (2008).
51. Richards, W. O., et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann. Surg. 240, 405-412 (2004).
52. Chen, Z., et al. Laparoscopic cardiomyotomy for achalasia: clinical outcomes beyond 5 years. J. Gastrointest. Surg. 14, 594-600 (2010).
53. Bonatti, H., et al. Long-term results of laparoscopic Heller myotomy with partial fundoplication for the treatment of achalasia. Am. J. Surg. 190, 874-878 (2005). (Pubitemid 41674615)
54. Kilic, A., et al. Long-term outcomes of laparoscopic Heller myotomy for achalasia. Surgery 146, 826-831 (2009).
55. Costantini, M., et al. The laparoscopic Heller-Dor operation remains an effective treatment for esophageal achalasia at a minimum 6-year follow-up. Surg. Endosc. 19, 345-351 (2006). (Pubitemid 40897931)
56. Wang, Y. R., et al. Trends of Heller myotomy hospitalizations for achalasia in the United States, 1993-2005: effect of surgery volume on perioperative outcomes. Am. J. Gastroenterol. 103, 2454-2464 (2008).
57. Cowgill, S. M. Difficult myotomy is not determined by preoperative therapy and does not impact outcome. JSLS 11, 336-343 (2007).
58. Portale, G., et al. Long-term outcome of laparoscopic Heller-Dor surgery for esophageal achalasia: possible detrimental role of previous endoscopic treatment. J. Gastrointest. Surg. 9, 1332-1339 (2005). (Pubitemid 41751128)
59. Smith, C. D. Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than heller myotomy alone. Ann. Surg. 243, 579-584 (2006). (Pubitemid 44305564)
60. Schuchert, M. J. Minimally-invasive esophagomyotomy in 200 consecutive patients: factors influencing postoperative outcomes. Ann. Thorac. Surg. 85, 1729-1734 (2008). (Pubitemid 351608147)
61. Finley, C. J., et al. Factors associated with postoperative symptoms after laparoscopic Heller myotomy. Ann. Thorac. Surg. 89, 392-396 (2010).
62. Roll, G. R. Excellent outcomes of laparoscopic esophagomyotomy for achalasia in patients older than 60 years of age. Surg. Endosc. 24, 2562-2566 (2010).
63. Mattioli, S., et al. Long-term results of the Heller-Dor operation with intraoperative manometry for the treatment of esophageal achalasia. J. Thorac. Cardiovasc. Surg. 140, 962-969 (2010).
64. Endo, S., et al. Laparoscopic Heller-Dor surgery for esophageal achalasia: impact of intraoperative real-time manometric feedback on postoperative outcomes. Dig. Surg. 26, 342-348 (2009).
65. Horgan, S., et al. Robotic-assisted Heller myotomy versus laparoscopic Heller myotomy for the treatment of esophageal achalasia: multicenter study. J. Gastrointest. Surg. 9, 1020-1029 (2005).
66. Huffmanm, L. C., et al. Robotic Heller myotomy: a safe operation with higher postoperative quality-of-life indices. Surgery 142, 613-618 (2007).
67. Gockel, I., et al. Heller myotomy for failed pneumatic dilation in achalasia: how effective is it? Ann. Surg. 239, 371-377 (2004). (Pubitemid 38229066)
68. Gockel, I., Junginger, T. & Eckardt, V. F. Persistent and recurrent achalasia after Heller myotomy: analysis of different patterns and long-term results of reoperation. Arch. Surg. 142, 1093-1097 (2007). (Pubitemid 350157047)
69. Guardino, J. M., et al. Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy. J. Clin. Gastroenterol. 38, 855-860 (2004). (Pubitemid 39410944)
70. Eldaif, S. M., et al. The risk of esophageal resection after esophagomyotomy for achalasia. Ann. Thorac. Surg. 87, 1558-1562 (2009).
71. Gockel, I., et al. Subtotal esophageal resection in motility disorders of the esophagus. Dig. Dis. 22, 396-401 (2004). (Pubitemid 41201482)
72. Duranceau, A., et al. End-stage achalasia. Dis. Esophagus doi:10.1111/j.1442-2050.2010.01157.x
73. Wang, L. A systematic review and meta-analysis of the Chinese literature for the treatment of achalasia. World J. Gastroenterol. 14, 5900-5906 (2008).
74. Lopushinsky, S. R. & Urbach, D. R. Pneumatic dilatation and surgical myotomy for achalasia. JAMA 296, 2227-2233 (2006). (Pubitemid 44708053)
75. Vela, M. F. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin. Gastroenterol. Hepatol. 4, 580-587 (2006).
76. Csendes, A., et al. Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut 30, 299-304 (1989). (Pubitemid 19091153)
77. Csendes, A., et al. Very late results of esophagomyotomy for patients with achalasia: clinical, endoscopic, histologic, manometric, and acid reflux studies in 67 patients for a mean follow-up of 190 months. Ann. Surg. 243, 196-203 (2006). (Pubitemid 43185438)
78. Boeckxstaens, G. E., et al. Pneumodilation versus laparoscopic Heller myotomy for idiopathic achalasia. N. Engl. J. Med. (in press).
79. Inoue, H., et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 42, 265-271 (2010).
80. Stavropoulos, S., et al. Endoscopic submucosal myotomy for the treatment of achalasia (with video). Gastrointest. Endosc. 72, 1309-1311 (2010).
81. Cheng,Y. S., et al. Temporary self-expanding metallic stents for achalasia: a prospective study with a long-term follow-up. World J. Gastroenterol. 16, 5111-5117 (2010).
82. Zhao, J. G., et al. Long-term safety and outcome of a temporary self-expanding metallic stent for achalasia: a prospective study with a 13-year single-center experience. Eur. Radiol. 19, 1973-1980 (2009).
83. Li, Y. D., et al. 13-year follow-up of a prospective comparison of the long-term clinical efficacy of temporary self-expanding metallic stents and pneumatic dilatation for the treatment of achalasia in 120 patients. AJR Am. J. Roentgenol. 195, 1429-1437 (2010).
84. Li, Y. D., et al. Temporary self-expanding metallic stents and pneumatic dilation for the treatment of achalasia: a prospective study with a long-term follow-up. Dis. Esophagus 23, 361-367 (2010).
85. Oezcelik, A., et al. An improved method of assessing esophageal emptying using the timed barium study following surgical myotomy for achalasia. J. Gastrointest. Surg. 13, 14-18 (2009).
86. Eckardt, V. F., et al. Risk factors for diagnostic delay in achalasia. Dig. Dis. Sci. 42, 580-585 (1997). (Pubitemid 27148345)
87. Gockel, I. & Junginger, T. The value of scoring achalasia: a comparison of current systems and the impact on treatment-the surgeons viewpoint Am. Surg. 73, 327-331 (2007). (Pubitemid 351396672)
88. Pohl, D. & Tutuian, R. Achalasia: an overview of diagnosis and treatment. J. Gastrointest. Liver Dis. 16, 297-303 (2007). (Pubitemid 47518394)
89. Bravi, I., et al. A pneumatic dilation strategy in achalasia: prospective outcome and effects on oesophageal motor function in the long term. Aliment. Pharmacol. Ther. 31, 658-665 (2010).
90. Mattioli, S., et al. Surgery for esophageal achalasia. long-term results with three different techniques. Hepatogastroenterology 43, 492-500 (1996).
91. Chuong, J. J., DuBovik, S. & McCallum, R. W. Achalasia as a risk factor for esophageal carcinoma. A reappraisal. Dig. Dis. Sci. 29, 1105-1108 (1984). (Pubitemid 15181477)
92. Meijssen, M. A., et al. Achalasia complicated by oesophageal squamous cell carcinoma: a prospective study in 195 patients Gut 33, 155-158 (1992).
93. Aggestrup, S., Holm, J. C. & Srensen, H. R. Does achalasia predispose to cancer of the esophagus? Chest 102, 1013-1016 (1996).
94. Sandler, R. S., et al. The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA 274, 1359-1362 (1995).
95. Brücher, B. L., et al. Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J. Surg. 25, 745-749 (2001). (Pubitemid 32531921)
96. Zaninotto, G., et al. Long-term outcome and risk of oesophageal cancer after surgery for achalasia. Br. J. Surg. 95, 1488-1494 (2008).
97. Leeuwenburgh, I., et al. Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am. J. Gastroenterol. 105, 2144-2149 (2010).
98. Zendehdel, K., et al. Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden. Am. J. Gastroenterol. 106, 57-61 (2011).
99. Hirota, W. K., et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest. Endosc. 63, 570-580 (2006).
100. Eckardt, A. J. & Eckardt, V. F. Editorial: cancer surveillance in achalasia: better late than never? Am. J. Gastroenterol. 105, 2150-2152 (2010).
101. Dunaway, P. M. & Wong, R. K. Risk and surveillance intervals for squamous cell carcinoma in achalasia. Gastrointest. Endosc. Clin. N. Am. 11, 425-434 (2001).